Massmutual Trust Co. FSB ADV decreased its holdings in shares of Express Scripts Holding (NASDAQ:ESRX) by 81.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,767 shares of the company’s stock after selling 33,951 shares during the period. Massmutual Trust Co. FSB ADV’s holdings in Express Scripts were worth $372,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in ESRX. SG Americas Securities LLC purchased a new position in Express Scripts during the third quarter worth about $2,090,000. Ameriprise Financial Inc. raised its holdings in Express Scripts by 23.5% during the third quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after purchasing an additional 996,816 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its holdings in Express Scripts by 38.9% during the third quarter. Thompson Siegel & Walmsley LLC now owns 126,592 shares of the company’s stock worth $8,016,000 after purchasing an additional 35,429 shares in the last quarter. Mawer Investment Management Ltd. raised its holdings in Express Scripts by 2.1% during the third quarter. Mawer Investment Management Ltd. now owns 358,637 shares of the company’s stock worth $22,709,000 after purchasing an additional 7,410 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Express Scripts by 24.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 287,630 shares of the company’s stock valued at $18,213,000 after buying an additional 56,105 shares in the last quarter. Institutional investors and hedge funds own 89.44% of the company’s stock.
In related news, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Christine Houston sold 19,889 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 31,681 shares of company stock worth $2,435,102. 0.68% of the stock is owned by company insiders.
A number of research analysts have issued reports on ESRX shares. Maxim Group increased their target price on shares of Express Scripts from $87.00 to $101.00 in a report on Wednesday, February 28th. TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a report on Monday, December 4th. Jefferies Group set a $80.00 target price on shares of Express Scripts and gave the company a “buy” rating in a report on Friday, December 15th. SunTrust Banks set a $82.00 target price on shares of Express Scripts and gave the company a “buy” rating in a report on Thursday, December 14th. Finally, BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday, December 14th. Three equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $81.97.
Express Scripts stock opened at $71.68 on Thursday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $85.07. The firm has a market cap of $40,644.78, a P/E ratio of 9.15, a PEG ratio of 0.89 and a beta of 0.94.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.07. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business had revenue of $25.38 billion during the quarter, compared to analysts’ expectations of $25.07 billion. During the same period last year, the company posted $1.88 EPS. The company’s revenue was up 2.1% on a year-over-year basis. research analysts predict that Express Scripts Holding will post 9.35 earnings per share for the current year.
Express Scripts announced that its Board of Directors has initiated a share buyback program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.
ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/03/22/massmutual-trust-co-fsb-adv-sells-33951-shares-of-express-scripts-holding-esrx.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.